2000
DOI: 10.1086/503214
|View full text |Cite
|
Sign up to set email alerts
|

Survival ofAcinetobacteron Three Clinically Related Inanimate Surfaces

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
30
0
2

Year Published

2002
2002
2016
2016

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(32 citation statements)
references
References 5 publications
0
30
0
2
Order By: Relevance
“…Patients can carry the microorganism for months, and their skin and mucosa can act as a source of cross contamination. Furthermore, the hands of healthcare workers may act as direct vectors for spread, while a contaminated environ- 325 ment may serve as a secondary source (15). In our study, the epidemic strain was not recovered from the hands of the healthcare workers but was found on the surface of a serum container located in the room of an outbreak patient.…”
mentioning
confidence: 64%
“…Patients can carry the microorganism for months, and their skin and mucosa can act as a source of cross contamination. Furthermore, the hands of healthcare workers may act as direct vectors for spread, while a contaminated environ- 325 ment may serve as a secondary source (15). In our study, the epidemic strain was not recovered from the hands of the healthcare workers but was found on the surface of a serum container located in the room of an outbreak patient.…”
mentioning
confidence: 64%
“…This Gram-negative, aerobic, coccobacillus is responsible for a significant number of hospital-acquired infections, including those of the skin and bloodstream, as well as pneumonia and meningitis (5,6,18,34,47). Importantly, A. baumannii is able to persist on hospital surfaces for weeks to months, providing an environmental reservoir for its transmission (44)(45)(46). Compounding this problem, multidrug-resistant (MDR) strains of A. baumannii have been isolated with increasing frequency, and strains with pan-drug resistance (PDR) have been described as well, particularly among vulnerable patients within intensive care units or military hospitals (3,11,15,33,36,39,41).…”
mentioning
confidence: 99%
“…Specific inhibitors of the FAS-II pathway include triclosan and thiolactomycin. Triclosan, a specific inhibitor of FAS-II trans-2-enoyl-ACP reductase (ENR, also known as inhA or FabI) is effective against a broad spectrum of bacteria (20), including Escherichia coli (21,22), mycobacteria (23), and multidrug-resistant Staphylococcus aureus (24,25) and is widely used as an antimicrobial in household formulations, including soaps and toothpaste. Recently, triclosan was found to inhibit P. falciparum growth with an IC 50 of Ïł1 M (19,26).…”
mentioning
confidence: 99%